Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer

SIMPLE SUMMARY: Pancreatic cancer is a clinically heterogeneous disease, and treatment leads to different outcomes for people with similar diagnoses. Identifying patients who may respond to chemotherapy and thereby benefit from improved survival has important implications for treatment protocols. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Muranaka, Hayato, Hendifar, Andrew, Osipov, Arsen, Moshayedi, Natalie, Placencio-Hickok, Veronica, Tatonetti, Nicholas, Stotland, Aleksandr, Parker, Sarah, Van Eyk, Jennifer, Pandol, Stephen J., Bhowmick, Neil A., Gong, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252041/
https://www.ncbi.nlm.nih.gov/pubmed/37296982
http://dx.doi.org/10.3390/cancers15113020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252041/
https://www.ncbi.nlm.nih.gov/pubmed/37296982
http://dx.doi.org/10.3390/cancers15113020

Ejemplares similares